scholarly article | Q13442814 |
P50 | author | Timothy J Johnson | Q56384059 |
Evgeni V Sokurenko | Q87688229 | ||
Lance B Price | Q88740953 | ||
James R Johnson | Q89498724 | ||
Paul Thuras | Q114444668 | ||
Veronika Tchesnokova | Q116019136 | ||
P2093 | author name string | Stephen B Porter | |
P2860 | cites work | Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients | Q33558863 |
Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations | Q33722011 | ||
Escherichia coli ST131, an intriguing clonal group | Q34057648 | ||
Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones | Q35332818 | ||
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli | Q36607290 | ||
Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections | Q37028442 | ||
Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans | Q37220795 | ||
Tolerance of Escherichia coli to fluoroquinolone antibiotics depends on specific components of the SOS response pathway | Q37320586 | ||
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx | Q37408471 | ||
Transmission of an extended-spectrum-beta-lactamase-producing Escherichia coli (sequence type ST131) strain between a father and daughter resulting in septic shock and Emphysematous pyelonephritis | Q37410500 | ||
Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts | Q37562424 | ||
Global dissemination of a multidrug resistant Escherichia coli clone | Q37711903 | ||
Joint tolerance to beta-lactam and fluoroquinolone antibiotics in Escherichia coli results from overexpression of hipA. | Q39559720 | ||
Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. | Q40028752 | ||
Intensity and Mechanisms of Fluoroquinolone Resistance within the H30 and H30Rx Subclones of Escherichia coli Sequence Type 131 Compared with Other Fluoroquinolone-Resistant E. coli | Q41220729 | ||
Post-prostate biopsy infection with Escherichia coli ST131 leading to epididymo-orchitis and meningitis caused by Gram-negative bacilli | Q41639920 | ||
Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-beta-lactamase-producing Escherichia coli isolates | Q41810485 | ||
Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates | Q42234726 | ||
Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States | Q43007779 | ||
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. | Q52247046 | ||
Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen. | Q53133655 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pandemic | Q12184 |
Escherichia coli | Q25419 | ||
P304 | page(s) | 7132-7135 | |
P577 | publication date | 2015-08-31 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Greater ciprofloxacin tolerance as a possible selectable phenotype underlying the pandemic spread of the H30 subclone of Escherichia coli sequence type 131. | |
P478 | volume | 59 |
Q90167602 | Activity of imipenem/relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, co-resistance, and region |
Q36325629 | Bacterial clonal diagnostics as a tool for evidence-based empiric antibiotic selection |
Q90218796 | Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents |
Q30386217 | The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts. |
Search more.